Sale of 16,141 shares at $26.9341 per share.
Reporting Person Bernstein Harold · Officer Title President, R&D & CMO · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0002050172-26-000038 · filed 2026-10-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Maze Therapeutics, Inc. (MAZE)." Disclosed 2026-10-02. https://desqlong.com/cards/0002050172-26-000038-2 (retrieved 2026-10-03).